+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

GLP-1 Market: Industry Trends and Global Forecasts, Till 2035 - Product Thumbnail Image

GLP-1 Market: Industry Trends and Global Forecasts, Till 2035

  • Report
  • December 2025
  • 218 Pages
  • Global
From
Glucagon Like Peptide-1 Agonists Market - Global Forecast 2026-2032 - Product Thumbnail Image

Glucagon Like Peptide-1 Agonists Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Glucagon-like Peptide 1 Market Report 2026 - Product Thumbnail Image

Glucagon-like Peptide 1 Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • May 2025
  • 300 Pages
  • Global
From
Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • October 2025
  • 160 Pages
  • Global
From
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 300 Pages
  • Europe
From
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 - Product Thumbnail Image

GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033

  • Report
  • October 2025
  • 456 Pages
  • Global
From
Glucagon-Like Peptide 1 Agonists Market - Global Strategic Business Report - Product Thumbnail Image

Glucagon-Like Peptide 1 Agonists Market - Global Strategic Business Report

  • Report
  • March 2026
  • 375 Pages
  • Global
From
GLP-1 Agonists Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

GLP-1 Agonists Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • United States
From
Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Diabetes Therapeutics and Diagnostics

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), DPP-4 Inhibitors), Age Group (Children, Adult, Elderly), Region, with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), DPP-4 Inhibitors), Age Group (Children, Adult, Elderly), Region, with Growth Forecasts, 2025-2030

  • Report
  • April 2025
  • 134 Pages
  • Global
From
Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2025 - 2035 - Product Thumbnail Image

Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2025 - 2035

  • Report
  • April 2025
  • 100 Pages
  • Global
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Diabetes Type (Type 1, 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Diabetes Type (Type 1, 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • April 2025
  • 100 Pages
  • Global
From
Semaglutide Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Thumbnail Image

Semaglutide Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • May 2025
  • 200 Pages
  • Global
From
Rapid Acting Insulin Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Thumbnail Image

Rapid Acting Insulin Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • May 2025
  • 200 Pages
  • Global
From
Diabetes Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetes Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Semaglutide Preparations Market - Global Forecast 2026-2032 - Product Thumbnail Image

Semaglutide Preparations Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 199 Pages
  • Global
From
Linagliptin & Metformin Hydrochloride Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Linagliptin & Metformin Hydrochloride Tablets Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more